Notice of third-party allocation paid-in capital increase

Hello, shareholder, I wish you good health and good luck in your family.

There has been a great deal of development outwardly, and it has been possible with the support and support of the shareholders, and I would like to express my gratitude to the shareholders. As the Board of Directors of 2020. 12. 10. has decided to issue new shares for the purpose of raising operating funds as follows, the Company shall notify the Stockholder in accordance with Article 418(4) of the Commercial Act.

1. Type and number of new shares: registered common stock 718,400 shares

2. Issued value of new shares: 20,880 won per share (extra 500 won in face value)

3. How to issue new shares: Third party allocation method (according to Article 418 (2) of the Commercial Act and Article 9-2-11 of the articles of association)

4. Purpose of Financing: Achieving Management Purpose and Rapid Financing [Finance of Operational Funds]

5. Total issuance of new shares: 15,000,192,000 won

6. Subject to the issuance of new shares

7. Date of lead entry: 2020.12.24

8. Other matters

A) Other details on the issue of new shares are delegated to the CEO.

B) This paid-in capital increase schedule may be changed according to the adjustment process of the relevant agencies.

C) Handling of real-rights shares: If a person subject to allocation does not subscribe to or acquire shares, he/she shall not issue them.

As mentioned above, we are notifying you of the paid-in capital increase for third-party assignment. If you have any questions, please contact us by December 23, 2020.

(031-214-9401, hepark@microbes.bio)

December 10th, 2020

HEM INC.​